[ Visit Client Website ]

Before you can access ASH's online program, you must agree to the following:
  • Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
  • The media, companies and institutions issuing press releases, and others are required to abide by the embargo policies governing the Society’s annual meeting. Read ASH’s embargo policy for more information.
-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session .

625.O2.6 625. Lymphoma - Pre-Clinical - Chemotherapy and Biologic Agents: Novel In vivo Models of Lymphoma Therapy

Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 9, 2012: 4:30 PM-6:00 PM
B405-B407, Level 4, Building B (Georgia World Congress Center)
Moderators:
Jeremy S. Abramson, MD, Massachusetts General Hospital Cancer Center and Xavier Leleu, MD, Hopital Huriez, CHRU

Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Shuo Yang, PhD1*, Marina G Damiano, BS2*, Heng Zhang, PhD3*, Sushant Tripathy, BS4*, Andrey Ugolkov, MD, PhD5*, Amareshwar T.K. Singh, PhD6*, Andrea Luthi, BS7*, Sandeep S. Dave, MD, MS8, Shad Thaxton, MD, PhD3* and Leo I. Gordon, MD9

1Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
2Chemistry, Northwestern University, Chicago, IL
3Urology, Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
4Center for Developmental Therapeutics, Northwestern University, Evanston, IL
5Center for Developmental Therapeutics, Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center, Evanston, IL
6Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
7Chemistry, Northwestern University, Evanston, IL
8Institute for Genome Sciences and Policy, Duke University, Durham, NC
9Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL

4:45 PM

Gabriele Pozzato, MD1, Nelly Mezzaroba, PhD2*, Sonia Zorzet, PhD3*, Erika Secco, PhD4*, Stefania Biffi, PhD5*, Claudio Tripodo, MD6*, Marco Calvaruso, MD7*, Luis Nuñez, PhD8*, Rubens Spretz, PhD9*, Gustavo Larsen, PhD9,10*, Sandra Noriega, PhD9*, Chiara Garrovo, PhD4*, Gustavo Marin, MD, PhD11*, Edoardo Mansilla, MD11* and Paolo Macor, PhD12*

1Department of Medical and Surgical Sciences, University of Trieste, Trieste, Italy
2Department of Life Science, University of Trieste, Trieste, Italy
3Department of Life Sciences, University of Trieste, Trieste, Italy
4Department of Life Sciences, University of Trieste, Trieste, Italy
5Optical Imaging Laboratory, Area Science Park, Trieste, Italy
6Department of Health Science, Human Pathology Section, University of Palermo, Palermo, Italy
7Department of Human Pathology, University of Palermo, Palermo, Italy
8University of Chicago, Chicago, IL
9LNK Chemosolutions, Lincoln, NV
10Bio-Target, Chicago, IL
11CUCAIBA, Ministry of Health, Buenos Aires, Argentina
12Dept. of Life Sciences, University of Trieste, Trieste, Italy

5:15 PM

Utthara Nayar, PhD1*, Gunkut Akar1*, Robert H Shoemaker, PhD2*, Shizuko Sei, MD3* and Ethel Cesarman, MD, PhD4

1Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY
2Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, MD
3NCI-Frederick, Frederick, MD
4Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY

5:30 PM

Sharon Shacham, PhD MBA1*, Sandra Barnard, BVSc2*, William Kisseberth, DVM, PhD2*, Daisuke Ito, DVM PhD3*, Kiersten Jensen4*, Antonella Borgotti, DVM MS3*, Michael Henson, DVM PhD3*, Heather Wilson, DVM5*, Dilara McCauley, PhD1*, Jaime Modiano, DVM PhD6*, Michael Kauffman, MD, PhD1 and Cheryl London, DVM PhD2*

1Karyopharm Therapeutics, Natick, MA
2Veterinary Clinical Sciences, Ohio State University, Columbus, OH
3Veterinary Clinical Sciences, University of Minnesota, St. Paul, MN
4Veterinary Clinical Sciences, University of Minnesota, St. Paul
5Veterinary Medicine, Texas A&M University, College Station, TX
6Veterinary Clinical Sciences, University of Minnesota, St Paul, MN

5:45 PM

Fuliang Chu, PhD1, Jason R. Westin, MD1, Min Zhang, Ph.D.2*, Lei Feng3*, Veerabhadran Baladandayuthapani, PhD4*, Zhiqiang Wang5*, Rochelle Allen, RN1*, Michael Wallace, MD6*, Luis Vence7*, Laszlo Radvanyi8*, Larry W. Kwak, MD, PhD9, Rinat Rotem-Yehudar, PhD10*, R Eric Davis11* and Sattva S. Neelapu, MD2

1Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
2Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Texas MD Anderson Cancer Center, Houston, TX
4Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
5Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
6Diagnostic Radiology, The University of Texas MD Anderson Cancer Center
7Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
8Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Hoston, TX
9Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
10CureTech, Ltd., Israel
11Lymphoma and Myeloma, University of Texas, Houston, TX

*signifies non-member of ASH